Canyon Pharmaceuticals, Inc. trademarks

Canyon Pharmaceuticals, Inc. owns 4 U.S. trademark filings (0 live registrations), with 2 TTAB proceedings. See filings by year, classes, attorneys and…

Recent trademark filings

• THROMBOEMBOLIC PROTECTION FOR PATIENTS AT RISK OF THROMBOCYTOPENIA
• IPREVASC
• THROMBOEMBOLIC PROTECTION FOR PATIENTS AT RISK OF THROMBOCYTOPENIA
• REVASC

View the full Canyon Pharmaceuticals, Inc. trademark profile on Marksy